Precision-standardized, HPLC-verified, Phytosome-complexed botanical compounds engineered for objective biometric outcomes — designed, manufactured, and validated under pharmaceutical-grade systems.
The sleep supplement category is currently served by three failing archetypes. At the commodity end: generic melatonin pills — cheap, chemically simple, and backed by decades of evidence that exogenous melatonin dysregulates endogenous production when used nightly. In the mass-market middle, powder-based Ayurvedic and herbal stacks — tradition-anchored but using raw unstandardized herb powders at sub-clinical doses, often with zero human RCT data. At the premium tier, influencer-promoted nutraceutical stacks built on 2–3 isolated compounds (magnesium, theanine, apigenin) — pharmacologically reasonable but one-dimensional and missing the system-level effects that actually govern sleep architecture.
Our formulation is the only sleep supplement on the market that is simultaneously:
No competitor formula, including the entire melatonin category, achieves any two of these four criteria simultaneously.
Our pipeline reflects a disciplined approach to evidence-based botanical product development. Each initiative passes through pre-formulation, locked specification, clinical validation, and commercial-scale production gates before launch.
A 1,018 mg per-serving active payload comprising nine HPLC-standardized botanical actives and primary adaptogens, engineered around a sunflower-derived Phytosome® phospholipid delivery matrix for enhanced bioavailability of lipophilic constituents. Mechanistic architecture organized around three convergent pharmacological pillars: GABAergic modulation, HPA-axis regulation, and slow-wave sleep architecture support.
Pre-registered 30-subject Decentralized Wearable Validation Study (DWVS) employing continuous biometric capture via Oura Ring Generation 4 sensor architecture. Within-subject longitudinal design, 49-day protocol, primary endpoints locked at study registration. Data lock scheduled Q3 2026.
Multi-pillar IP framework established. Provisional patent application filed covering composition of matter and technology-integrated methods of use, with trademark and design protections in active prosecution. Full disclosure available to verified partners under executed Mutual Non-Disclosure and Non-Circumvention agreements.
The technical specifications below define the minimum manufacturing capability required for any Contract Manufacturing Organization or analytical partner to engage with our product portfolio. These standards exist to protect formulation integrity, biometric efficacy, and finished-goods stability — and to filter for partners whose infrastructure matches the precision of our science.
Multi-stage geometric dilution sequencing for all formulations containing micro-dose actives below 75 mg. Documented seed-blend creation, intermediate stage verification, and final blend uniformity testing targeting RSD ≤3% on low-dose constituents.
Dedicated blending and encapsulation rooms maintained at ≤35% Relative Humidity and ≤22°C ambient temperature throughout production. Continuous environmental logging with documented RH data accompanying every batch record.
All raw material lots subject to third-party ISO-17025 accredited HPLC identity and potency verification. Finished blend uniformity testing with acceptance criterion of ≤6% RSD across total blend.
Encapsulated finished goods tested for Water Activity (Aw) with acceptance criterion of ≤0.35 prior to bottling. Primary packaging specifies dark amber glass with desiccant. 90-day accelerated stability protocols and 12-month real-time stability monitoring performed on every commercial production run.
Ayurveda Herbal Corp is led by a focused team integrating commercial strategy, technical operations, and credentialed clinical advisory across modern dietary supplement science and classical Ayurvedic systems.
Leads corporate strategy, formulation oversight, and commercial development. Background spans dietary supplement formulation, brand development, and direct-to-consumer commerce.
Leads marketing strategy, brand positioning, and commercial communications for the corporate portfolio. Brings integrated expertise in market development, digital outreach, and audience engagement across health and wellness categories.
Provides clinical oversight of formulation safety, mechanism rationale, and Ayurvedic systems architecture. BAMS-credentialed Ayurvedic practitioner with deep expertise in classical formulation science and modern standardization protocols. nishalwellness.com
Our specialized advisory network includes BAMS-credentialed Ayurvedic clinical practitioners, senior pharmacognosists with expertise in standardized botanical extracts, and registered toxicology consultants. The network provides ongoing review of formulation safety profiles, mechanistic rationale, regulatory positioning, and clinical study design. Individual advisors disclosed to verified partners under confidentiality.
This site is a corporate identity reference for verified supply chain partners, raw material distributors, and cGMP-certified contract manufacturers. We do not publish consumer-facing product information here. Verified industry partners may submit corporate verification requests to access full technical documentation and partnership terms.
Submit your details below and our partnership team will respond within five business days with the appropriate next steps for documentation access and engagement structure.